Canada markets open in 6 hours 4 minutes

Outlook Therapeutics, Inc. (OTLK)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
8.19-0.01 (-0.12%)
At close: 04:00PM EDT
8.08 -0.11 (-1.34%)
After hours: 07:43PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 190.81M
Enterprise Value 217.00M
Trailing P/E N/A
Forward P/E 2.85
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)13.27
Price/Book (mrq)N/A
Enterprise Value/Revenue 23.71
Enterprise Value/EBITDA -4.17

Trading Information

Stock Price History

Beta (5Y Monthly) 0.19
52-Week Change 3-61.00%
S&P500 52-Week Change 321.08%
52 Week High 340.60
52 Week Low 34.00
50-Day Moving Average 38.51
200-Day Moving Average 311.92

Share Statistics

Avg Vol (3 month) 3643.33k
Avg Vol (10 day) 3241.49k
Shares Outstanding 523.3M
Implied Shares Outstanding 623.33M
Float 85.87M
% Held by Insiders 138.85%
% Held by Institutions 122.74%
Shares Short (Apr 15, 2024) 41.13M
Short Ratio (Apr 15, 2024) 40.68
Short % of Float (Apr 15, 2024) 45.78%
Short % of Shares Outstanding (Apr 15, 2024) 44.85%
Shares Short (prior month Mar 15, 2024) 4785.3k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 18, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Mar 14, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-70.76%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -47.7M
Net Income Avi to Common (ttm)-51.5M
Diluted EPS (ttm)-4.00
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)10.36M
Total Cash Per Share (mrq)0.8
Total Debt (mrq)36.55M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.44
Book Value Per Share (mrq)-1.87

Cash Flow Statement

Operating Cash Flow (ttm)-47.1M
Levered Free Cash Flow (ttm)-30.69M